ArticleVaccines2021

Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2.

Tuksin Jearanaiwitayakul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.